Оценка структуры атеросклеротических бляшек коронарных артерий у больных хронической ишемической болезнью сердца по данным внутрисосудистого ультразвукового исследования со спектральным анализом радиочастотных данных
Скачать 0.9 Mb.
|
Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005; 111(25): 3481-3488. Loftus I.M., Naylor A.R., Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: A potential role in acute plaque disruption. Stroke. 2000; 31: 40 – 47. Loscalzo J. Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis. 1990; 10(5): 672–679. Mallery J.A., Tobis J.M., Griffith J., et al. Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J. 1990; 119(6): 1392-1400. Matsumoto Y., Daida H., Watanabe Y., et al., High level of lipoprotein(a) is a strong predictor for progression of coronary artery disease. J Atheroscler Thromb. 1998; 5: 47–53. Milionis H.J., Winder A.F., Mikhailidis D.P. Lipoprotein (a) and stroke. Journal of Clinical Pathology. 2000; 53(7): 487–496. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001; 37(5): 1478–1492. Mintz G.S., Pichard A.D., Kovach J.A., et al. Impact of preintervention intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease. Am J Cardiol. 1994; 73(7): 423–430. Mintz G.S., Pichard A.D., Popma J.J., et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol. 1997; 29: 268–274. Missel E., Mintz G.S., Carlier S.G. In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J. 2008; 29: 2141-2147. Missel E., Mintz G.S., Carlier S.G., et al. Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. Am J Cardiol. 2008; 101(5): 573-578. Mizgala H.F., Gray L.H., Ferris J.A., et al. Coronary artery luminal narrowing in the young with sudden unexpected death: a coroner’s autopsy study in 350 subjects age 40 years and under. Can J Cardiol. 1993; 9: 33– 40. Moore M.P., Spencer T., Salter D.M., et al. Characterisation of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: in vitro intravascular ultrasound study with histological and radiological validation. Heart. 1998; 79(5): 459-467. Mooser V., Marcovina S.M., Wang J., et al. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay. Clinical Genetics. 1997; 52(5): 387–392. Mooser V., Marcovina S.M., White A.L., et al. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. Journal of Clinical Investigation. 1996; 98(10): 2414–2424. Morita Y., Himeno H., Yakuwa H., et al. Serum lipoprotein(a) level and clinical coronary stenosis progression in patients with myocardial infarction: re-revascularization rate is high in patients with high-Lp(a). Circulation. 2006; 70(2): 156–162. Motta M., Giugno I., Bosco S., et al. Serum lipoprotein(a) changes in acute myocardial infarction. Panminerva Medica. 2001; 43(2): 77–80. Mullenix P.S., Andersen C.A., Starnes B.W. Atherosclerosis as inflammation. Ann Vasc Surg. 2005; 19(1): 130-138. Myers G.L., Christenson R.H., Cushman M., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem. 2009; 55(2): 378-384. Naghavi M., Falk E., Hecht H.S., et al. From vulnerable plaque to vulnerable patient. Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006; 98(2A): 2H-15H. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108(14): 1664-1672. Nair A., Kuban B.D., Tuzcu E.M., et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002; 106: 2200–2206. Nair A., Margolis M.P., Kuban B.D., et al. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention. 2007; 3: 113–120. Nakamura M., Nishikawa H., Mukai S., et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 2001; 37: 63-69. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol. 2006; 47(12): 2405–2412. Nicholls S.J., Tuzcu E.M., Crowe T., et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol. 2006; 47(10): 1967-1975. Nilsson L., Jonasson L., Nijm J., et al. Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin Chem. 2006: 52(8): 1522-1527. Nishimura R.A., Edwards W.D., Warnes C.A., et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol. 1990; 16: 145-154. Nishioka T., Amanullah A.M., Luo H., et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J Am Coll Cardiol. 1999; 33: 1870–1878. Nissen S.E. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Med. 2005; 118(12A): 22-27. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295: 1556–1565. Nissen S.E., Nicholls S.J., Wolski K., et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008; 299: 1547–1560. Nissen S.E., Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001; 103: 604–616. Noji Y., Kajinami K., Kawashiri M., et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med. 2001; 39: 380–384. O’Rourke R.A., Brundage B.H., Froelicher V.F., et al. American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000; 102: 126–140. Oida K., Takai H., Maeda H., et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clinical Chemistry. 1992; 38(11): 2244–2248. Omoto R. Ultrasonic intravenous sonde. -2-nd reporte. Med Ultrasound. 1963; l: l. Otake H., Shite J., Shinke T., et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol. 2008; 101: 1 – 7. Paffen E., DeMaat M.P. C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res. 2006; 71(1): 30-39. Park J.P., Lee B.K., Shim J.M., et al. Relationship between multiple plasma biomarkers and vulnerable plaque determined by virtual histology intravascular ultrasound. Circ J. 2010; 74(2): 332-336. Pasceri V., Cheng J.S., Willerson J.T., et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001; 103:2531–2534. Peters R.J., Kok W.E., Havenith M.G., et al. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr. 1994; 7: 230-241. Philipp S., Böse D., Wijns W., et al. Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Eur Heart J. 2010; 31(2): 196-202. Poon M., Zhang X., Dunsky K., et al. Apolipoprotein(a) is a human vascular endothelial cell agonist: studies on the induction in endothelial cells of monocyte chemotactic factor activity. Clinical Genetics. 1997; 52(5): 308–313. Prasad A., Cipher D.J., Prasad A., et al. Reproducibility of intravascular ultrasound virtual histology analysis. Cardiovasc Revasc Med. 2008; 9: 71—77. Pundziute G., Schuijf J.D., Jukema J.W., et al. Head-to-head comparison of coronary plaque evaluation between multislice computed tomography and intravascular ultrasound radiofrequency data analysis. JACC Cardiovasc Interv. 2008; 1(2): 176-182. Qian J., Maehara A., Mintz G.S., et al. Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). Am J Cardiol. 2009;103(9): 1210-1214. Rader D.J., Hoeg J.M., Brewer H.B. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994; 120: 1012–1025. Rdzanek A., Kochman J., Pietrasik A., et al. The prevalence of potentially unstable coronary lesions in patients with coronary artery disease - virtual histology study. Kardiol Pol. 2008; 66(3): 244-250. Ridker P.M., Cannon C.P., Morrow D., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352(1): 20-28. Ridker P.M., Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004; 109(16): 1955-1959. Ridker P.M., Morrow D.A., Rose L.M., et al. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol. 2005; 45(10): 1644-1648. Rioufol G., Finet G., Ginon I., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation. 2002; 106: 804–808. Rodriguez-Granillo G.A., Garcia-Garcia H.M., Mc Fadden E.P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol. 2005; 46: 2038-2042. Rodriguez-Granillo G.A., McFadden E.P., Valgimigli M. Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation. Am Heart J. 2006; 151: 1020-1024. Rodriguez-Granillo G.A., Serruys P.W., Garcia-Garcia H.M., et al. Coronary artery remodelling is related to plaque composition. Heart. 2006; 92: 388–391. Rodriguez-Granillo G.A., Serruys P.W., McFadden E.P., et al. First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudy. EuroIntervention. 2005; 1(3): 282 - 288. Rogers J.H., Wegelin J., Harder K., et al. Assessment of FFR-negative intermediate coronary artery stenoses by spectral analysis of the radiofrequency intravascular ultrasound signal. J Invasive Cardiol. 2006; 18(10): 448-453. Sandholzer C., Saha N., Kark J.D., et al. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arteriosclerosis and trombosis. 1992; 12(10): 1214–1226. Scanu A.M. Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations. Biochemical Pharmacology. 1993; 46(10): 1675–1680. Schwartzman R.A., Cox I.D., Poloniecki J., et al. Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. Journal of the American College of Cardiology. 1998; 31(6): 1260–1266. Shah P.K. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol. 2003; 41: 15–22. Sipahi I., Tuzcu E.M., Moon K.W., et al. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study. Heart. 2008; 94: 623–627. Sipahi I., Tuzcu E.M., Schoenhagen P., et al. Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial. Atherosclerosis. 2006; 189(1): 229-235. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: A study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke. 2006; 37: 235 – 239. Smith S.C. Jr., Feldman T.E., Hirshfeld J.W. Jr., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: A. report of the American College of Cardiology/American Heart Association task force on practice guidelines (acc/aha/scai writing committee to update the 2001 guidelines for percutaneous coronary intervention). Circulation. 2006; 113: 156–178. St. Goar F.G., Pinto F.J., Alderman E.L., et al. Intravascular ultrasound imaging of angiographically normal coronary arteries: an in vivo comparison with quantitative angiography. J Am Coll Cardiol. 1991; 18(4): 952–958. Stone G.W., Maehara A., Lansky A.J., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364: 226-235. Surmely J.F., Nasu K., Fujita H., Coronary plaque composition of culprit/target lesions according to the clinical presentation: a virtual histology intravascular ultrasound analysis. Eur Heart J. 2006; 27: 2939-2944. Tabas A., Li H., Brocia M., et al. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. Journal of Biological Chemistry. 1993; 268(27): 20419–20432. Takagi A., Tsurumi Y., Ishii Y., et al. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation. 1999; 100(3): 250–255. Takami S., Yamashita S., Kihara S., et al. Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation. 1998; 97(8): 721–728. Tamura A., Watanabe T., Mikuriya Y., et al. Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction. British Heart Journal. 1995; 74(4): 365–369. Tanindi A., Sahinarslan A., Elbeg S., et al. Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease. Open Cardiovasc Med J. 2011; 5: 110-116. |
Похожие:
 | Медикаментозная терапия хронической ишемической болезни сердца Цикл тематического усовершенствования «Новые технологии диагностики и лечения терапевтических больных» |  | Влияние метеорологической и геомагнитной активности на гемодинамику... Источник: Тайм-менеджмент: Практикум по управлению временем. — Спб.: Речь, 2006. 371с |
| 2. Патология клапанов сердца (пороки) Тема Заболевания коронарных артерий сердца В ходе экзамена он должен продемонстрировать глубокое понимание как основ медицинской науки, так и проблемных вопросов в отдельных... | | Эффективность и безопасность эндоваскулярных вмешательств у больных... Работа выполнена на кафедре кардиологии и общей терапии фгу «Учебно-научный медицинский центр» Управления делами Президента Российской... |
| Отдаленные результаты эндоваскулярного лечения при использовании... Работа выполнена в Лаборатории рентгенологии и ангиографических методов исследований и Отделе заболеваний миокарда и сердечной недостаточности... | | I период До внедрения в клинику принципов интенсивного коронарных больных, аритмии были непосредственной причиной смерти не менее чем в 40%... |
| I период До внедрения в клинику принципов интенсивного коронарных больных, аритмии были непосредственной причиной смерти не менее чем в 40%... | | Коррекция дислипидемий и гемостазиологических нарушений у пациентов... Работа выполнена в Государственном образовательном учреждении высшего профессионального образования «Самарский государственный медицинский... |
| «Реваскуляризация миокарда при ишемической болезни сердца: методы,... Цикл общего усовершенствования «Новые технологии диагностики и лечения терапевтических больных» | | Исследование ассоциации ряда генов-кандидатов с ишемической болезнью сердца Работа выполнена в лаборатории молекулярной диагностики и геномной дактилоскопии фгуп «Государственный научно-исследовательский институт... |
| Одномоментное многоуровневое шунтирование при полисегментарном и... Примерные вопросы к кандидатскому экзамену по дисииплине история и философия науки | | Лечебное питание для больных хронической болезнью почек (хбп) ... |
| «Диагностика ишемической болезни сердца в форме стенокардии» Охватывают до 165 см тела человека за один оборот рентгеновской трубки (около 0,3с). Продолжительность сканирования сердца снизилась... | | Исследование механизмов прогрессирования, путей повышения продолжительности,... Перинатальные исходы и их улучшение при осложненном течении беременности и родов. №01201055841 |
| Особенности нарушения биомеханики малого круга кровообращения и центральной... Работа выполнена в Государственном бюджетном образовательном учреждении высшего профессионального образования «Самарский государственный... | | Элемент был выделен в 1886 году из смеси редкоземельных элементов... Элемент был выделен в 1886 году из смеси редкоземельных элементов французским химиком Э. А. Демарсе. Его существование было подтверждено... |
